Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
44°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Collegium Pharmaceutical, Inc.
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER
April 29, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
April 25, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
April 11, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
February 22, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
February 08, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Provides 2024 Financial Guidance
January 03, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
November 27, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Announces $25 Million Accelerated Share Repurchase Program
November 09, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Participate in Upcoming Investor Conferences
November 08, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023
August 28, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
August 24, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Announces $50 Million Accelerated Share Repurchase Program
August 07, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
August 03, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023
July 20, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Participate in Jefferies Healthcare Conference
June 01, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports First Quarter 2023 Financial Results
May 04, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Report First Quarter 2023 Financial Results on May 4, 2023
April 20, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
February 23, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report
February 22, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
February 07, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering
February 06, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
February 06, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Provides 2023 Financial Guidance
January 04, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
December 22, 2022
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Collegium Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Tickers
COLL
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.